Stereotaxis Announces Definitive Agreement to Acquire Robocath - Stereotaxis (AMEX:STXS)

Stereotaxis to buy Robocath for up to $45M

The deal combines Stereotaxis’ magnetic navigation technology and Robocath’s mechanical robotic system, strengthening Stereotaxis’ position in endovascular surgery, said CEO David Fischel.

Stereotaxis Announces Definitive Agreement to Acquire Robocath - Stereotaxis (AMEX:STXS)

ST. LOUIS and ROUEN, France, April 15, 2026 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE:STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it has entered into a definitive agreement to acquire Robocath, a venture-backed innovator of robotic technologies for interventional cardiology and neurointerventions. This acquisition significantly strengthens Stereotaxis' position as a l…

Stereotaxis to acquire Robocath for up to $45M

The next-generation Robocath surgical robot is in use during a first-in-human trial. Stereotaxis has agreed to acquire the technology. | Source: Robocath Stereotaxis announced today that it agreed to acquire surgical robot developer Robocath. The transaction includes an upfront payment of $20 million and additional contingent payments of up to $25 million tied to regulatory and commercial milestones, including FDA clearance of the company’s next…

Stereotaxis to acquire Robocath - BioTuesdays

Stereotaxis (NYSE: STXS) has announced that it has entered into a definitive agreement to acquire closely held Robocath, a venture-backed innovator of robotic techniques for interventional cardiology and neurointerventions, based in France. According to Stereotaxis, the acquisition strengthens its leadership position in endovascular care by combining technologies into fully integrated robotic solutions for electrophysiology, interventional cardi…